Keith D. Dawkins

The impact of chronic kidney disease on outcomes following percutaneous coronary intervention versus coronary artery bypass grafting in patients with complex coronary artery disease: five-year follow-up of the SYNTAX trial

Milojevic M, Head S, Mack M, Mohr F, Morice M, Dawkins K, Holmes D, Serruys P, Kappetein A

May 20, 2018 | 10.4244/EIJ-D-17-00620

Impact of bioresorbable versus permanent polymer on long-term vessel wall inflammation and healing: a comparative drug-eluting stent experimental study

Wilson G, McGregor J, Conditt G, Shibuya M, Sushkova N, Eppihimer M, Hawley S, Rousselle S, Huibregtse B, Dawkins K, Granada J

February 20, 2018 | 10.4244/EIJ-D-17-00332

A randomised comparison of biodegradable polymer- and permanent polymer-coated platinum-chromium everolimus-eluting coronary stents in China: the EVOLVE China study

Han Y, Liu H, Yang Y, Zhang J, Xu K, Fu G, Su X, Jiang T, Pang W, Chen J, Yuan Z, Li H, Wang H, Hong T, Liu H, Sun F, Allocco DJ, Zhang M, Dawkins K

November 20, 2017 | 10.4244/EIJ-D-17-00271

Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients

Meredith I, Dumonteil N, Blackman DJ, Tchetché D, Walters D, Hildick-Smith D, Manoharan G, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Feldman T, Allocco DJ, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01024

Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort

Dumonteil N, Meredith I, Blackman DJ, Tchetché D, Hildick-Smith D, Spence M, Walters D, Harnek J, Worthley S, Rioufol G, Lefèvre T, Modine T, Van Mieghem NM, Houle V, Allocco DJ, Dawkins K

September 20, 2017 | 10.4244/EIJ-D-16-01025

Does geographical variability influence five-year MACCE rates in the multicentre SYNTAX revascularisation trial?

Roy A, Chevalier B, Lefèvre T, Louvard Y, Segurado R, Sawaya F, Spaziano M, Neylon A, Serruys P, Dawkins K, Kappetein A, Mohr F, Colombo A, Feldman T, Morice M

September 20, 2017 | 10.4244/EIJ-D-16-00991

Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudy

Kereiakes D, Meredith I, Masotti M, Carrié D, Moreno R, Erglis A, Mehta S, Elhadad S, Berland J, Stein B, Airaksinen J, Jobe R, Reitman A, Janssens L, Christen T, Dawkins K, Windecker S

March 20, 2017 | 10.4244/EIJ-D-16-00643

Fluorocopolymer-coated nitinol self-expanding paclitaxel-eluting stent: pharmacokinetics and vascular biology responses in a porcine iliofemoral model

Hou D, Huibregtse B, Eppihimer M, Stoffregen W, Kocur G, Hitzman C, Stejskal E, Heil J, Dawkins K

August 20, 2016 | 10.4244/EIJV12I6A128

Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study

Watkins S, Oldroyd K, Preda I, Holmes D, Colombo A, Morice M, Leadley K, Dawkins K, Mohr F, Serruys P, Feldman T

April 20, 2015 | 10.4244/EIJV10I12A244

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco DJ, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_01

One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study

Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_07

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study

Meredith I, Worthley S, Whitbourn R, Antonis P, Montarello J, Newcomb A, Lockwood S, Haratani N, Allocco DJ, Dawkins K

March 20, 2014 | 10.4244/EIJV9I11A216

The coronary artery bypass graft SYNTAX Score: final five-year outcomes from the SYNTAX-LE MANS left main angiographic substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

December 27, 2013 | 10.4244/EIJV9I8A170

Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent

Meredith I, Verheye S, Weissman N, Barragan P, Scott D, Valdés Chávarri M, West N, Kelbæk H, Whitbourn R, Walters D, Kubica J, Thuesen L, Masotti M, Banning A, Sjogren I, Stables R, Allocco DJ, Dawkins K

July 26, 2013 | 10.4244/EIJV9I3A52

The CABG SYNTAX Score - an angiographic tool to grade the complexity of coronary disease following coronary artery bypass graft surgery: from the SYNTAX Left Main Angiographic (SYNTAX-LE MANS) substudy

Farooq V, Girasis C, Magro M, Onuma Y, Morel M, Heo J, Garcia-Garcia H, Kappetein A, van den Brand M, Holmes D, Mack M, Feldman T, Colombo A, Stahle E, James S, Carrié D, Fournial G, Van Es G-A, Dawkins K, Mohr F, Morice M, Serruys P

March 22, 2013 | 10.4244/EIJV8I11A196

Boston Scientific Lotus valve

Meredith I, Hood K, Haratani N, Allocco DJ, Dawkins K

September 30, 2012 | 10.4244/EIJV8SQA12

Vasomotor function and re-endothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a time-course study

Nakamura T, Winsor-Hines D, Yin X, Sushkova N, Chen J, King S, Chronos N, Eppihimer M, Huibregtse B, Dawkins K, Hou D

August 24, 2012 | 10.4244/EIJV8I4A77

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trials

Kereiakes D, Popma J, Cannon L, Kandzari D, Kimmelstiel C, Meredith I, Teirstein P, Verheye S, Allocco DJ, Dawkins K, Stone G

June 27, 2012 | 10.4244/EIJV8I2A32

Comparison of the SYNERGY with the PROMUS (XIENCE V) and bare metal and polymer-only Element control stents in porcine coronary arteries

Wilson G, Huibregtse B, Pennington D, Dawkins K

June 27, 2012 | 10.4244/EIJV8I2A39

Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS)

Morice M, Feldman T, Mack M, Stahle E, Holmes D, Colombo A, Morel M, van den Brand M, Serruys P, Mohr F, Carrié D, Fournial G, James S, Leadley K, Dawkins K, Kappetein A

October 28, 2011 | 10.4244/EIJV7I6A109

Keith D. Dawkins

Latest news